Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Reversal of Neuromuscular Blockade on the Amplitude of Motor Evoked Potentials: A Randomized Controlled Crossover Study Comparing Sugammadex and Placebo

NCT03087513 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT03087513
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03087513 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Reversal of Neuromuscular Blockade on the Amplitude of Motor Evoked Potentials: A Randomized Controlled Crossover Study Comparing Sugammadex and Placebo
Lead sponsor
University Health Network, Toronto
Phase
Phase 4
Overall status
Completed
Start date
February 5, 2018
Completion date
April 30, 2020
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

posterior cervical decompression and fusion